BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 16301125)

  • 1. Late relapse of testicular germ cell tumors.
    Carver BS; Motzer RJ; Kondagunta GV; Sogani PG; Sheinfeld J
    Urol Oncol; 2005; 23(6):441-5. PubMed ID: 16301125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial comment on "Late relapse of testicular germ cell tumors".
    Vaughn DJ
    Urol Oncol; 2005; 23(6):445-6. PubMed ID: 16301126
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical study of six cases showing late relapse of germ cell tumors.
    Muramaki M; Hara I; Miyake H; Yamada Y; Kawabata G; Kamidono S
    Int J Urol; 2005 Sep; 12(9):855-8. PubMed ID: 16201988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late relapse of testis cancer.
    Ehrlich Y; Baniel J
    Urol Clin North Am; 2007 May; 34(2):253-8; abstract x-xi. PubMed ID: 17484930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late relapse of germ cell tumors.
    Oldenburg J; Lorch A; Fosså SD
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):615-26, x. PubMed ID: 21570613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late relapses of germ cell malignancies: incidence, management, and prognosis.
    Oldenburg J; Martin JM; Fosså SD
    J Clin Oncol; 2006 Dec; 24(35):5503-11. PubMed ID: 17158535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance versus nerve-sparing retroperitoneal lymphadenectomy in stage I nonseminomatous germ-cell tumors.
    Lowe BA
    Urol Clin North Am; 1993 Feb; 20(1):75-83. PubMed ID: 8381999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The indication for postchemotherapy lymph node dissection in clinical stage IS nonseminomatous germ cell tumor.
    Dash A; Carver BS; Stasi J; Bajorin DF; Motzer RJ; Bosl GJ; Sheinfeld J
    Cancer; 2008 Feb; 112(4):800-5. PubMed ID: 18172902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?
    Divrik RT; Akdoğan B; Ozen H; Zorlu F
    J Urol; 2006 Oct; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late Relapse of Testicular Germ Cell Tumors.
    O'Shaughnessy MJ; Feldman DR; Carver BS; Sheinfeld J
    Urol Clin North Am; 2015 Aug; 42(3):359-68. PubMed ID: 26216823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonoperative approach for the management of clinical stage A nonseminomatous germ cell tumors.
    Jewett MA
    Semin Urol; 1984 Nov; 2(4):204-7. PubMed ID: 6095394
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonseminomatous testicular cancer.
    Freiha F
    J Med Liban; 2005; 53(2):91-4. PubMed ID: 16604994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance and outcome of patients with stage 1 non-seminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centres.
    Ernst DS; Brasher P; Venner PM; Czaykowski P; Moore MJ; Reyno L; Winquist E; Segal R; Hao D
    Can J Urol; 2005 Apr; 12(2):2575-80. PubMed ID: 15877938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved clinical outcome in recent years for men with metastatic nonseminomatous germ cell tumors.
    Carver BS; Serio AM; Bajorin D; Motzer RJ; Stasi J; Bosl GJ; Vickers AJ; Sheinfeld J
    J Clin Oncol; 2007 Dec; 25(35):5603-8. PubMed ID: 17998544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Germ cell tumors of the testis].
    Krainer M; Kührer I; Kratzik C
    Wien Klin Wochenschr; 1994; 106(2):37-44. PubMed ID: 8146994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current management of stage I testicular non-seminomatous germ cell tumours.
    Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
    Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late recurrence in 1263 men with testicular germ cell tumors. Multivariate analysis of risk factors and implications for management.
    Shahidi M; Norman AR; Dearnaley DP; Nicholls J; Horwich A; Huddart RA
    Cancer; 2002 Aug; 95(3):520-30. PubMed ID: 12209744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
    Ondrus D; Ondrusova M; Hornak M; Matoska J
    Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histologic type, staging, and distribution of germ cell tumors in Korean adults.
    Park DS; Chung MK; Chung JI; Ahn HJ; Lee ES; Choi HY; Yoon DK; Cheon J; Hong SJ; Lee YG; Yoon SM; Kim WJ; Kim HJ; Ryu SB; Ro JY
    Urol Oncol; 2008; 26(6):590-4. PubMed ID: 18367106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-risk-adapted surveillance in clinical stage I nonseminomatous germ cell tumors: the Princess Margaret Hospital's experience.
    Sturgeon JF; Moore MJ; Kakiashvili DM; Duran I; Anson-Cartwright LC; Berthold DR; Warde PR; Gospodarowicz MK; Alison RE; Liu J; Ma C; Pond GR; Jewett MA
    Eur Urol; 2011 Apr; 59(4):556-62. PubMed ID: 21190791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.